Hinge Health (NYSE:HNGE) issues earnings results, beats estimates by $0.44 EPS. Hinge Health (NYSE:HNGE - Get Free Report) released its quarterly earnings results on Monday. The company reported $0.71 EPS for the quarter, topping the consensus estimate of $0.27 by $0.44, FiscalAI reports. Hinge Health had a return on equity of 51.60% and a net margin of 15.15%. The company had revenue of $234.97 million for the quarter. During the same period last year, the firm earned ($0.02) EPS. The company's quarterly revenue was up 52.4% on a year-over-year basis. Here are the key takeaways from Hinge Health's conference call: * Q3 results exceeded expectations, with revenue up 52% year over year to $235 million, an 88% gross margin, a 33% operating margin, and $120 million in free cash flow. The company raised its full-year 2026 revenue guidance to $879 million-$881 million and operating income guidance to $266 million-$268 million. * Commercial momentum accelerated, with contracted clients up 28% year over year to 3,270, nearly 1 million SMB lives added through Q3, and more than 10 million lives across over 800 clients gaining access to multiple Hinge Health products. Management also cited rising win rates, strong health-plan partnerships, and increased member enrollment and renewals. * Early results from the Migraine Care Program were encouraging, including a 23% reduction in monthly migraine days, a 28% reduction in attack duration, and clinically meaningful HIT-6 improvements for more than half of surveyed members. Migraine access has expanded to roughly 9 million lives, with most launches expected in early 2027. * Hinge plans to launch its integrated GI Care Program in summer 2027, but management expects the offering's revenue contribution to become meaningful mainly in 2028. The company is currently selling Cylinder's existing GI solution and has expanded its GI client base by approximately 40% since announcing the acquisition. * President Jim Pursley will step down at year-end to spend more time with his family and join Hinge Health's board, with Chief Commercial Officer Aaryn Pure taking over go-to-market leadership. Management characterized the transition as orderly, but the change introduces leadership-transition risk. Hinge Health stock performance. Shares of HNGE opened at $115.11 on Tuesday. The stock has a market capitalization of $9.29 billion, a P/E ratio of 89.93 and a beta of 1.37. The company's fifty day moving average is $98.66 and its two-hundred day moving average is $67.35. Hinge Health has a 1 year low of $30.08 and a 1 year high of $118.87. Key stories impacting Hinge Health. Here are the key news stories impacting Hinge Health this week: * Quarterly results exceeded consensus. Hinge Health generated approximately $235.0 million in revenue, up 52.4% year over year, and reported $0.71 in earnings per share versus estimates ranging from $0.27 to $0.63. The company also posted a 15.15% net margin, reinforcing the improving profitability story. * Management provided a constructive growth outlook. Hinge Health outlined 2026 revenue of $879 million to $881 million, representing another upward outlook adjustment according to coverage of the earnings call. The company also is targeting an integrated gastrointestinal care program for summer 2027, creating a potential new expansion opportunity beyond its core musculoskeletal business. * The earnings reaction was relatively limited. Although Hinge Health cleared published estimates and highlighted record results, reports characterized the stock's response as muted. With a market capitalization near $9.3 billion, a price-to-earnings ratio around 89, and shares close to their one-year high, much of the strong execution may already be reflected in the valuation. * Expectations remain a key risk. Some coverage indicated that results missed the higher "whisper" forecast despite beating official consensus estimates. That gap, combined with the stock's sharp appreciation above its 50-day and 200-day moving averages, could limit further gains unless Hinge Health continues delivering sizable revenue growth and upward guidance revisions. Insider activity. In other news, CEO Daniel Perez sold 150,000 shares of the firm's stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $89.44, for a total value of $13,416,000.00. Following the completion of the sale, the chief executive officer owned 35,470 shares in the company, valued at approximately $3,172,436.80. This trade represents a 80.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Chairman Gabriel Mecklenburg sold 250,000 shares of Hinge Health stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $88.97, for a total transaction of $22,242,500.00. Following the completion of the sale, the chairman directly owned 250,000 shares in the company, valued at approximately $22,242,500. The trade was a 50.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,024,581 shares of company stock worth $95,632,761 in the last 90 days. Corporate insiders own 18.92% of the company's stock. Institutional investors weigh in on Hinge Health. Institutional investors have recently added to or reduced their stakes in the business. IFP Advisors Inc raised its stake in shares of Hinge Health by 140.0% during the 2nd quarter. IFP Advisors Inc now owns 324 shares of the company's stock worth $27,000 after buying an additional 189 shares in the last quarter. Nykredit A S acquired a new stake in shares of Hinge Health in the 2nd quarter valued at approximately $29,000. SBI Securities Co. Ltd. boosted its stake in shares of Hinge Health by 39.5% in the third quarter. SBI Securities Co. Ltd. now owns 364 shares of the company's stock valued at $35,000 after buying an additional 103 shares in the last quarter. State of Wyoming purchased a new stake in shares of Hinge Health in the first quarter valued at approximately $110,000. Finally, Sterling Capital Management LLC boosted its stake in shares of Hinge Health by 899.3% in the third quarter. Sterling Capital Management LLC now owns 1,469 shares of the company's stock valued at $143,000 after buying an additional 1,322 shares in the last quarter. Analyst upgrades and downgrades. A number of analysts recently weighed in on HNGE shares. Royal Bank Of Canada increased their price target on shares of Hinge Health from $75.00 to $110.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 5th. Barclays increased their target price on shares of Hinge Health from $100.00 to $110.00 and gave the stock an "overweight" rating in a research note on Monday, October 12th. Truist Financial boosted their price target on Hinge Health from $85.00 to $112.00 and gave the company a "buy" rating in a research report on Monday, August 10th. Stifel Nicolaus boosted their price target on Hinge Health from $130.00 to $135.00 and gave the company a "buy" rating in a research report on Tuesday. Finally, Evercore reaffirmed an "outperform" rating and set a $105.00 price objective on shares of Hinge Health in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, Hinge Health has a consensus rating of "Moderate Buy" and an average target price of $111.60. About Hinge Health. Hinge Health is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care programs designed to help members manage pain, improve mobility and reduce the need for more costly or invasive treatments. Its platform combines personalized exercise therapy, behavioral support, education and access to clinical professionals. Hinge Health also uses technologies such as motion-sensing wearable devices and artificial intelligence to help guide exercises, monitor progress and tailor care plans to individual needs. Hinge Health primarily serves employers and health plans, which offer its programs to eligible members in the United States. Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.

Hinge Health reported third-quarter revenue of $235 million, up 52% from $154 million a year earlier and above its guidance of $223 million to $225 million. The digital musculoskeletal care company posted an 88% gross margin and a 33% non-GAAP operating margin. It raised its 2026 revenue forecast to $879 million–$881 million from $856 million–$860 million. Its operating income outlook rose to $266 million–$268 million. The company cited higher member engagement and growth from its Cylinder acquisition. Contracted clients grew 28% to 3,270. Free cash flow was $120 million. President Jim Pursley will step down at the end of 2026 and join the board. Chief commercial officer Aaryn Pure will lead go-to-market.

What Hinge Health (HNGE) said on its Q3 earnings call. Hinge Health (NYSE:HNGE) reported third-quarter revenue growth of 52% year over year and raised its full-year outlook, as the digital musculoskeletal care company cited higher member engagement, client additions and improved operating leverage. Revenue for the third quarter was $235 million, compared with $154 million a year earlier and above the company's prior guidance range of $223 million to $225 million. Last-12-month calculated billings rose 54% to $960 million. The company reported an 88% gross margin, up 480 basis points from the prior-year period. Non-GAAP income from operations was $77 million, producing a 33% operating margin, compared with a 20% margin in the third quarter of 2025. Free cash flow, excluding $7 million of one-time acquisition-related payments, was $120 million, or a 51% margin. "Q3 was another strong proof point that automated care delivery works for our members, our clients, our partners, and our financials," Co-Founder and Chief Executive Officer Daniel Perez said. Guidance raised as yield improves. Chief Financial Officer James Budge said the quarterly revenue outperformance was driven by stronger-than-anticipated billings, which in turn reflected higher yield, or the portion of eligible members who enroll and engage with the company's programs. Hinge Health said members joining through clinically targeted enrollment campaigns increased nearly 75% year over year, while member renewals increased almost 25%. Budge said the company views those improvements as structural rather than one-time factors. For the fourth quarter, Hinge Health expects revenue of $249 million to $251 million, representing 46% growth at the midpoint. It forecast non-GAAP income from operations of $81 million to $83 million, or a 33% margin at the midpoint. For full-year 2026, the company raised its revenue outlook to $879 million to $881 million from a prior range of $856 million to $860 million. It also lifted its non-GAAP operating-income forecast to $266 million to $268 million, representing a 30% operating margin at the midpoint. The company now expects approximately 25.5 million last-12-month average eligible lives at year-end, about 500,000 above its prior expectation. Budge said the increase primarily reflects net new lives added through the acquisition of Cylinder. Hinge Health also increased its full-year yield assumption to 4.6% from 4.45%. Hinge Health ended the quarter with $358 million in cash and investments. During the quarter, it repurchased 296,000 shares for $26 million and reported $209 million in outflows related to acquisitions and net share settlements on employee restricted stock unit vestings. Commercial growth and leadership transition. Chief Commercial Officer Aaryn Pure said the company ended the quarter with 3,270 contracted clients, up 28% from a year earlier. Hinge Health added three Fortune 15 clients and expanded to serve the full population of another large client. The company said it closed nearly 1 million small- and medium-sized business, or SMB, lives through the third quarter. Pure said SMB sales can have faster sales cycles, higher initial yield and more favorable economics than larger-client sales. Hinge Health has already received verbal agreements for more eligible lives this year than it closed during all of the prior year, according to management. The company said more than 10 million lives across over 800 clients now have access to multiple Hinge Health products, including musculoskeletal care, migraine care, gastrointestinal care or HingeSelect. President Jim Pursley said he will step down from his executive role at the end of 2026 to spend more time with his family. He will join Hinge Health's board. Pure, who has worked with Pursley at both Hinge Health and Livongo, is set to lead the company's go-to-market function. The company said it has more than 60 health plan, pharmacy benefit manager and third-party administrator partners, with 100% health-plan retention. Pure said Hinge Health is listed as a preferred partner with more health plans than before and that those channel relationships have contributed to its sales growth. New programs expand beyond MSK. While management emphasized that core musculoskeletal, or MSK, care remains its largest revenue contributor, the company discussed progress in its newer migraine and GI offerings. Hinge Health's Migraine Care Program remains in early access. Perez said surveyed members showed a 23% reduction in monthly migraine days and a 28% reduction in migraine duration, or approximately five hours. About two-thirds of members improved their HIT-6 scores, a measure of migraine impact, while just over half achieved a clinically meaningful change. The migraine offering is available to approximately 9 million lives across more than 800 clients, following an expansion during the quarter. Most of those lives are expected to launch in early 2027. Budge said the company continues to expect migraine care to add roughly 10 to 20 basis points to yield in 2027, with a larger contribution expected over time. Hinge Health also said its acquisition of Cylinder has supported its expansion into GI care. Since announcing the acquisition in August, the company said it has grown Cylinder's GI client base by around 40%. The company is developing an integrated GI Care Program for the Hinge Health app, targeted for release in summer 2027. The planned product will include an AI-powered intake process, food analysis using photos, voice notes or text, symptom tracking, and an AI-powered stool scan based on the Bristol Stool Scale. It is also expected to provide members direct access to GI specialists, dietitians and gut-brain therapists, along with pelvic floor therapy. Management expects GI revenue contribution to become more meaningful in 2028, after a fuller 2027 selling season for the integrated offering. Budge said average selling prices are expected to remain roughly flat in 2027, with potential uplift in later periods as migraine and GI programs mature and more members use multiple programs. About Hinge Health (NYSE:HNGE). Hinge Health is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care programs designed to help members manage pain, improve mobility and reduce the need for more costly or invasive treatments. Its platform combines personalized exercise therapy, behavioral support, education and access to clinical professionals. Hinge Health also uses technologies such as motion-sensing wearable devices and artificial intelligence to help guide exercises, monitor progress and tailor care plans to individual needs. Hinge Health primarily serves employers and health plans, which offer its programs to eligible members in the United States.